Unincreased risk of hospitalized infection under targeted therapies versus methotrexate in elderly patients with rheumatoid arthritis: a retrospective cohort study

BACKGROUND: Infection is one of the primary concerns during treatment for rheumatoid arthritis (RA) in elderly patients. However, infection risk of patients with RA receiving targeted therapy (TT) including biological disease-modifying antirheumatic drugs (bDMARDs) and Janus kinase inhibitors (JAKIs...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Ryoko, Tanaka, Eiichi, Majima, Masako, Harigai, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185865/
https://www.ncbi.nlm.nih.gov/pubmed/35689250
http://dx.doi.org/10.1186/s13075-022-02807-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185865/
https://www.ncbi.nlm.nih.gov/pubmed/35689250
http://dx.doi.org/10.1186/s13075-022-02807-9

Ejemplares similares